Piper Sandler Starts Quest Diagnostics (DGX) at Neutral
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $236.04 -0.73%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Piper Sandler analyst David Westenberg initiates coverage on Quest Diagnostics (NYSE: DGX) with a Neutral rating and a price target of $145.00.
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $141.92 yesterday.
You May Also Be Interested In
- Quest Diagnostics (DGX) Declares $0.86 Quarterly Dividend; 1.4% Yield
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
- Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
